Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7340397 | 0.87 | CTSG (0.49) | ALDH1A1GAAKMT2AMEN1TAAR1 | |
| SCHEMBL31688471 | 0.87 | CTSG (0.49) | ALDH1A1GAAKMT2AMEN1TAAR1 | |
| Hydrochloric Acid SCHEMBL8065739 | 0.86 | CTSG (0.48) | ALDH1A1GAAKMT2AMEN1HTT | |
| SCHEMBL29855236 | 0.85 | ALDH1A1 (0.56) | MTNR1AMTNR1BALDH1A1GAAKMT2A | |
| SCHEMBL22444688 | 0.85 | ALDH1A1 (0.56) | MTNR1AMTNR1BALDH1A1GAAKMT2A | |
| SCHEMBL16203411 | 0.85 | ALDH1A1 (0.56) | MTNR1AMTNR1BALDH1A1GAAKMT2A | |
| SCHEMBL31688681 | 0.82 | MEN1 (0.53) | KMT2AMEN1 | |
| SCHEMBL21408984 | 0.80 | CTSK (0.54) | MTNR1AMTNR1BALDH1A1GAATSHR | |
| SCHEMBL12305802 | 0.80 | CTSK (0.54) | MTNR1AMTNR1BALDH1A1GAATSHR | |
| SCHEMBL8238588 | 0.80 | CTSK (0.54) | MTNR1AMTNR1BALDH1A1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | MTNR1A 3497/4885MTNR1B 3294/4885ALDH1A1 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.